However, each medication is intended for use over an extended period, as obesity is recognized as a chronic condition
Efficacy and safety comparison of liraglutide, glimepiride, and placebo, all in combination with metformin, in type 2 diabetes: the LEAD (Liraglutide Effect and Action in Diabetes)-2 study
The safer choice depends on contraindications, other medications, diabetes treatment, gastrointestinal history, pregnancy considerations, and individual tolerance
New to GLP-1 Therapy
Eligible beneficiaries pay a flat $50 monthly copay while CMS covers the remaining balance of the $245 monthly cost
Similarly, the Wegovy Savings Program offers discounts or introductory pricing that help patients begin treatment without relying on compounded substitutes